Skip to main content

Bill introduced to change SSDI benefits

I'm posting the following press release mainly as a kind of FYI - I know several readers recieve SSDI benefits. While I think that removing penalties to work is a great idea, I also believe that other issues surrounding SSDI also create obstacles to work, or to allowing people to do the most they can for themselves, whether that be full time, part time or self employment.

Currently it takes two years of being on SSDI to be eligable for Medicare, coverage that is typically a bit better than Medicaid. For people with vision loss due to potentially life threatening illness, two years is too long to wait for this coverage. Many people lose everything they've worked for all their lives while they wait.

After going through so much to obtain Medicare coverage, many people are reluctant to risk giving it up. It's not always just about losing benefits for an entry-level job. It's also often about health care survival.



Public Relations
National Federation of the Blind
(410) 659-9314, extension 2330
(410) 262-1281 (Cell)
cdanielsen@nfb.org
National Federation of the Blind Praises Bill to Create Work Incentives and Opportunity
Blind Persons Earnings Fairness Act
Introduced by Congressman Lewis
Washington, D.C. (October 16, 2007): Congressman John Lewis (D-GA) has introduced legislation designed to help blind persons receiving Social Security Disability Insurance (SSDI) to return to work. The Blind Persons Earnings Fairness Act of 2007 (H.R. 3834), which has already drawn bipartisan support, will eliminate penalties that prevent blind persons from reentering the workforce and will facilitate their transition to employment.

Dr. Marc Maurer, President of the National Federation of the Blind, which has long advocated this change in policy, said: “This proposal will allow thousands of blind people to rejoin the workforce and become productive, tax-paying citizens. Many blind people are understandably reluctant to take entry-level jobs because they are penalized by an immediate loss of SSDI benefits, and their work income rarely compensates for that loss. This legislation will allow blind persons to make a smooth transition from dependence to opportunity. We will work with Congressman Lewis to ensure the swift passage of this landmark legislation.”

Congressman Lewis said: “Americans who are blind deserve the same opportunities as all other Americans. Their blindness does not prevent them from making valuable contributions to our society, as evidenced by the many successful blind people I have personally met over the years. The gifts and opportunities of these citizens should not be hindered by policies that discourage them from entering the workforce. That is why I am proud to stand with my blind brothers and sisters and introduce this much-needed legislation.” The legislation will increase the amount of monthly income that a blind person can earn while still receiving SSDI benefits. The earnings limit will gradually rise from its current level of $1,500 per month to $2,850 per month in 2011. In 2012, the earnings limit for blind people will be tied to that applicable to senior citizens in the year they attain full retirement age.

# # #
About the National Federation of the Blind
With more than 50,000 members, the National Federation of the Blind is the largest and most influential membership organization of blind people in the United States. The NFB improves blind people’s lives through advocacy, education, research, technology, and programs encouraging independence and self-confidence. It is the leading force in the blindness field today and the voice of the nation's blind. In January 2004 the NFB opened the National Federation of the Blind Jernigan Institute, the first research and training center in the United States for the blind led by the blind.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria